Molecular basis of pathogenicity of the recently emerged FCoV-23 coronavirus
M. Alejandra Tortorici, Annette Choi, Cecily A. Gibson, Jimin Lee, Jack T Brown, Cameron Stewart, Anshu Joshi, Sheri Harari, Isabelle Willoughby, Catherine Treichel, Elizabeth M. Leaf, Jesse D. Bloom, Neil P. King, Christine Tait‐Burkard, Gary R. Whittaker, David Veesler
This study identifies molecular mechanisms of FCoV-23 pathogenicity, including receptor usage and biotype switching, and identifies a cross-reactive antibody for therapeutic development.
bioRxiv · Aug 25, 2024 · PreprintBiochemistry